Endopath-f Liquid
NDC Package 64578-0170-1
Package Information
Endopath-f (agnus, angelica sin, cimicifuga, fucus, glandula suprarenalis suis, glycyrrhiza, hypothalamus, oophorinum, pituitarum posterium, pulsatilla, sepia, thyroidinum, xanthoxylum) liquids is a human otc drug administered via oral route. This formulation utilizes a liquid delivery system. Marketed by Energetix Corporation, this product is identified by NDC 64578-0170.
Identification & Billing
Clinical Specifications
- ANGELICA SINENSIS ROOT 8 [hp_X]/59.1mL
- BLACK COHOSH 4 [hp_X]/59.1mL
- BOS TAURUS HYPOTHALAMUS 12 [hp_X]/59.1mL
- CHASTE TREE FRUIT 4 [hp_X]/59.1mL
- FUCUS VESICULOSUS 4 [hp_X]/59.1mL
- LICORICE 4 [hp_X]/59.1mL
- PULSATILLA VULGARIS 12 [hp_X]/59.1mL
- SEPIA OFFICINALIS JUICE 12 [hp_X]/59.1mL
- SUS SCROFA ADRENAL GLAND 9 [hp_X]/59.1mL
- SUS SCROFA OVARY 9 [hp_X]/59.1mL
- SUS SCROFA PITUITARY GLAND, POSTERIOR 12 [hp_X]/59.1mL
- THYROID, UNSPECIFIED 9 [hp_X]/59.1mL
- ZANTHOXYLUM AMERICANUM BARK 4 [hp_X]/59.1mL
Regulatory & Marketing
Hierarchy Structure
- 64578 - Energetix Corporation
- 64578-0170 - Endopath-f
- 64578-0170-1 - 59.1 mL in 1 BOTTLE
- 64578-0170 - Endopath-f
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64578-0170-1 identifies a specific commercial package of 59.1 ml in 1 bottle of Endopath-f, a human over the counter drug labeled by Energetix Corporation. This liquid is formulated for oral use and contains angelica sinensis root; black cohosh; bos taurus hypothalamus; chaste tree fruit; fucus vesiculosus; licorice; pulsatilla vulgaris; sepia officinalis juice; sus scrofa adrenal gland; sus scrofa ovary; sus scrofa pituitary gland, posterior; thyroid, unspecified; zanthoxylum americanum bark as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energetix Corporation on September 10, 2015. The current certification is valid through December 31, 2026.
How is this Energetix Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64578017001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.